Adaptive AI system identifies mental illness behaviors, modifies treatment plans
Summary
USPTO published patent application US20260094689A1 for an adaptive AI system that identifies behaviors associated with mental illness and modifies treatment plans. The system predicts typical and aberrant physiological reactions to psychiatric counseling using demographic and biometric data. Filed by Federal Leadership Institute, Inc.
What changed
This patent application (US20260094689A1, published April 2, 2026) covers an adaptive artificial intelligence system designed to predict typical and aberrant physiological reactions of patients undergoing psychiatric counseling. The system determines and calculates treatment plans based on demographic and biometric data, with the ability to modify plans based on emergent recognition of reaction types—reclassifying previously typical reactions as aberrant and vice versa. The application includes CPC classifications related to healthcare AI, medical data, and mental health diagnosis.
This is a patent application publication, not a binding regulatory requirement. Healthcare providers and technology companies developing similar AI-driven mental health tools should review the claims to understand potential patent landscape implications for their own product development. No compliance deadline or penalties are associated with this document. The application was filed on May 6, 2025, under application number 19200439.
Source document (simplified)
ADAPTIVE ARTIFICIAL INTELLIGENCE SYSTEM FOR IDENTIFYING BEHAVIORS ASSOCIATED WITH MENTAL ILLNESS AND MODIFYING TREATMENT PLANS BASED ON EMERGENT RECOGNITION OF ABERRANT REACTIONS
Application US20260094689A1 Kind: A1 Apr 02, 2026
Assignee
Federal Leadership Institute, Inc.
Inventors
Laura GRANATO, Michael M. KOHONOSKI, Thomas REIGLE
Abstract
One or more embodiments described herein relate to predicting, using adaptive artificial intelligence techniques, typical and aberrant physiological reactions of a patient to psychiatric counseling. Treatment plans can be determined and calculated based on previously-gathered demographic and/or biometric data, and/or modifications to treatment plans can be determined and/or implemented based on emergent recognition of reaction types, such as reclassifying reactions that would previously have been deemed typical as aberrant (or vice versa).
CPC Classifications
G16H 20/70 G06N 20/00 G16H 10/60 G16H 50/20 G16H 50/50 G16H 50/70
Filing Date
2025-05-06
Application No.
19200439
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Healthcare alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: Patent Apps - Health Informatics (G16H) publishes new changes.